• If you are wondering whether Welltower's current share price reflects its real worth, the numbers behind the stock give you plenty to think about.
• The stock last closed at US$210.00, with returns of 0.3% over 7 days, 7.3% over 30 days, 12.3% year to date, 43.2% over 1 year and 212.0% over 5 years.
• Recent attention on Welltower has focused on its position in the health care real estate space and how investors are treating large, income oriented property names. This context helps explain why sentiment around the stock and its price behavior has been so closely watched.
• Despite this backdrop, Welltower currently holds a valuation score of 0 out of 6. The next sections will walk through what different valuation methods say about the stock, and then finish with a way of thinking about valuation that goes a step further than the traditional models.

Welltower scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Welltower Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s value, aiming to estimate what the business might be worth right now. For Welltower, the model is based on adjusted funds from operations using a 2 stage Free Cash Flow to Equity approach.

Welltower’s latest twelve month free cash flow is about $1.82b. Analysts have supplied forecasts out to 2030, with Simply Wall St extending the path using its own assumptions beyond the explicit analyst window. By 2030, projected free cash flow is $5.71b, with annual figures stepping up through the late 2020s according to the provided schedule of estimates and extrapolations.

After discounting these future cash flows back to today, the model arrives at an estimated intrinsic value of $193.58 per share, compared with the recent share price of $210.00. That gap implies the stock is about 8.5% above the DCF estimate, so the model views the current price as close to, but somewhat richer than, its calculated fair value.

Result: ABOUT RIGHT

Welltower is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Approach 2: Welltower Price vs Sales

For profitable and revenue generating companies like Welltower, the P/S ratio can be a useful yardstick because it compares what the market is paying for each dollar of sales, regardless of capital structure or accounting choices that affect earnings.

In general, higher growth expectations and lower perceived risk can support a higher “normal” P/S ratio, while slower growth or higher uncertainty tend to line up with a lower multiple. So context matters when you look at the headline number.

Welltower currently trades on a P/S of 13.65x. That is above the Health Care REITs industry average of 7.09x and also above the peer average of 6.36x. Simply Wall St’s Fair Ratio for Welltower is 7.46x, which represents the P/S level suggested by factors such as earnings growth, industry, profit margin, market cap and risk profile.

This Fair Ratio is more tailored than a simple comparison with industry or peer averages because it adjusts for company specific characteristics rather than treating all REITs as identical. Setting 13.65x against the Fair Ratio of 7.46x indicates the shares are trading at a richer level than that model implies.

Result: OVERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Welltower Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach a clear story to the numbers by linking your view on a company like Welltower to explicit forecasts for revenue, earnings and margins. These then roll up into a Fair Value that you can compare with the current price to decide if it looks attractive or stretched. All of this is available within an easy Community page tool that updates automatically when fresh news or earnings are added. One investor might back a higher Fair Value around US$260.00 with assumptions closer to the more optimistic analyst cohort, while another might anchor closer to US$145.00 using more cautious revenue and margin expectations. Both perspectives are visible side by side so you can see which story you believe in.

For Welltower however, we will make it really easy for you with previews of two leading Welltower narratives:

Fair value in this bullish narrative: US$229.30 per share

Implied discount to that fair value at the current US$210.00 share price: about 8.4% lower than the narrative fair value

Revenue growth assumption used in this view: 18.08% a year

• Analysts backing this view see expansion efforts, acquisitions and the Welltower Business System supporting higher revenue and wider profit margins over time.
• The narrative leans on earnings growing to US$2.6b and a P/E of 92.6x by 2029, which is higher than the current Health Care REITs industry P/E cited for comparison.
• Risks in this scenario focus on macro conditions, acquisition related leverage and senior housing supply and occupancy, which could all affect margins and funding capacity.

Fair value in this bearish narrative: about US$191.07 per share

Implied premium to that fair value at the current US$210.00 share price: about 9.9% above the narrative fair value

Revenue growth assumption used in this view: 12.27% a year

• The more cautious view leans on slower assumed revenue growth, more modest margin gains and a fair value that lines up with the lower end of analyst targets.
• It highlights the potential impact of macro uncertainty, acquisition related leverage and higher interest costs on occupancy, earnings and net margins.
• This narrative still factors in growth drivers such as fund management and acquisitions, but concludes that the current market price may already expect a lot from those initiatives.

If you want to see how these bullish and bearish storylines translate into detailed numbers, side by side scenarios and updated fair values, you can review the full set of community views on Welltower to stress test your own expectations.

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Welltower on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Do you think there's more to the story for Welltower? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.